Last updated 2026-07-20
Portfolio
0
in our dataset
Rounds participated
0
Rounds led
0
Rounds' value
—
total disclosed, rounds participated
Stages
—
About
GreyBird Ventures is a venture capital firm that invests in and helps build companies focused on solving critical diagnostic problems in precision medicine. The firm aims to eliminate "trial and error" medicine with high-specificity diagnostics, generating value for patients, providers, therapy developers, and healthcare payers. They invest early and work closely with entrepreneurs who share their passion for precise disease diagnosis as the starting point for successful treatment.
Portfolio
No portfolio companies in this dataset yet.
Investment activity
Portfolio by sector
Health Tech & Life Sciences1
Q&A
- What is GreyBird Ventures' primary investment focus?
- GreyBird Ventures primarily focuses on the Health Tech & Life Sciences sector, with all of its portfolio companies in this area.
- Can you name a notable portfolio company of GreyBird Ventures?
- NeuroKaire, a company focused on precision medicine for psychiatry and neurology, is a portfolio company of GreyBird Ventures.
- What was GreyBird Ventures' most recent investment activity?
- GreyBird Ventures participated in an A Round investment in June 2024.
- What is the typical funding stage for GreyBird Ventures' investments?
- GreyBird Ventures has participated in A Round investments, including both initial and follow-on rounds.
- When did GreyBird Ventures make its first recorded investment?
- GreyBird Ventures made its first recorded investment in September 2021.
- What is the total amount raised by NeuroKaire, a GreyBird Ventures portfolio company?
- NeuroKaire has raised $25.27 million in funding.
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
Identifiers & details
| Legal name | GreyBird Ventures, LLC |
|---|---|
| Founded | 2013 |